1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Foundation Fader: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis Miltefosine + Imiquimod, Miltefosine 150 mg x day + Placebo - Cutaneous Leishmaniasis | Phase 2 | Completed | Foundation Fader | 60 | 2008-03-01 | 2011-06-27 |
| Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and Antimony Miltefosine and antimony, Miltefosine alone - Cutaneous Leishmaniasis | Phase 2 | Terminated | Foundation Fader | 19 | 2007-03-01 | 2011-06-27 |
Leishmaniasis (2) · Leishmaniasis, Cutaneous (2)
miltefosine (2) · Antimony (1) · Imiquimod (1)
Bolivia (2)